Two cases of plasma cell leukemia with atypical immunophenotype

Acta Haematologica

Volumn 118, Issue 1, 2007, Pages 27-29

  Buda, Gabriele ^a   Carulli, Giovanni ^a   Orciuolo, Enrico ^a   Cannizzo, Elisa ^a   Zucca, Alessandra ^a   Azzarà, Antonio ^a   Rossi, Angela ^a   Galimberti, Sara ^a   Cecconi, Nadia ^a   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD20 ANTIGEN; CD23 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; MELPHALAN; PLASMA PROTEIN; RITUXIMAB; SYNDECAN 1; VINCRISTINE;

ADULT; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOPHENOTYPING; LABORATORY TEST; MULTIPLE MYELOMA; PERFORMANCE; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, PLASMACYTIC; MIDDLE AGED; MULTIPLE MYELOMA; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 34347356569     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101557     Document Type: Article

References (15)

1. Jimenez-Zepeda VH, Dominguez VJ: Plasma cell leukemia: a rare condition. Ann Hematol 2006;85:263-267.
2. Spremolla G, Papineschi F, Petrini M, Daole G: Acute plasmacytic leukemia: clinical considerations and morphological, cytochemical and ultrastructural aspects (in Italian). Recenti Prog Med 1981;70:292-311.
3. Saccaro S, Fonseca R, Veillon DM, Cotelingam J, Nordberg ML, Bredeson C, Glass J, Munker R: Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature. Am J Hematol 2005;78:288-294.
4. Johnson MR, Del Carpio-Jayo D, Lin P, Giralt S, Anderlini P, Champlin RE, Khouri IF, Vadhan-Raj S, Medeiros LJ, Bueso-Ramos CE: Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation. Ann Diagn Pathol 2006;10:263-268.
5. Gemmel C, Cremer FW, Weis M, Witzens M, Moldenhauer G, Koniczek KH, Imbach U, Ho AD, Moos M, Goldschmidt H: Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation. Ann Hematol 2002;81:119-123.
6. Rajkumar SV, Kyle RA: Multiple myeloma: diagnosis and treatment. Mayo Clin Proc 2005;80:1371-1382.
7. Oka S, Yokote T, Akioka T, Hara S, Yamano T, Tsuji M, Hanafusa T: Successful treatment of multi-agent chemotherapy with rituximab for IgM plasma cell leukemia. Leuk Res 2006;30:1581-1583.
8. Ataergin S, Arpaci F, Kaya A, Kaya T, Gunhan O: VAD combination chemotherapy followed by bortezomib may be an effective treatment in secondary plasma cell leukemia. Am J Hematol 2006;81:987-988.
9. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B: Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999;341:1565-1571.
10. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ, Medical Research Council Adult Leukaemia Working Party: High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003;348:1875-1883.
11. Clark AD, Douglas KW, Mitchell LD, McQuaker IG, Parker AN, Tansey PJ, Franklin IM, Cook G: Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatment. Br J Haematol 2002;117:605-612.
12. Ruiz-Arguelles GJ, San Miguel JF: Cell surface markers in multiple myeloma. Mayo Clin Proc 1994;69:684-690.
13. Garcia-Sanz R, Orfao A, Gonzalez M, Tabernero MD, Blade J, Moro MJ, Fernandez-Calvo J, Sanz MA, Perez-Simon JA, Rasillo A, Miguel JF: Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood 1999;93:1032-1037.
14. Tanioka F, Tamashima S, Shimizu S, Kobayashi H, Kobayashi Y, Sugimura H: A case of primary plasma cell leukemia with hairy-cell morphology and λ-type Bence-Jones protein. Immunohistochemical and molecular analysis. Jpn J Clin Oncol 2003;33:232-237.
15. Finnegan DP, Kettle P, Drake M, Matthews C, Alexander HD, Popat R, Cavanagh JD, Wachsman W, Morris TC: Bortezomib is effective in primary plasma cell leukemia. Leuk Lymphoma 2006;47:1670-1673.